Health Canada open data (page 36)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Your cannabis questions, answered. Mental health. (0:16)
- Your cannabis questions, answered. Mood. (0:16)
- Your Cannabis Questions, Answered: How are THC and CBD different?
- Your Cannabis Questions, Answered: What are the risks of driving high? - Described video
- Your Cannabis Questions, Answered: How can a plant be harmful?
- Your Cannabis Questions, Answered: Are there risks to using cannabis?
- Cannabis and the border
- Reduce your risk: Choose legal cannabis
- Reduce Your Risk: Choose Legal Cannabis (infographic)
- Cannabis and your health
- Class exemption to prohibitions to possess and produce medical cannabis for medical purposes - Exemption for registered persons
- Class exemption to prohibitions to possess and produce medical cannabis for medical purposes - Exemption for designated persons
- Class exemption to prohibitions to possess and produce medical cannabis for medical purposes - Exemption for registered persons with a designated person
- Growing cannabis at home safely
- Regulations under the Cannabis Act
- Consumer Information – Cannabis
- Consumer Information - Cannabis (Marihuana, marijuana)
- Physical security measures guide for cannabis: Requirements under Part 4 of the Cannabis Regulations
- Cannabis health warning messages
- Tolerance Limits for the Net Weight and Volume Declared on Cannabis Product Labelling
- Medical document authorizing the use of cannabis for medical purposes
- Security Clearance Fingerprint Third Party Consent to Release Personal Information - Cannabis Act
- Section 56 Class Exemption in Relation to the Access to Cannabis for Medical Purposes Regulations - Physical Security Requirements for Applicants for a Licence to Produce Cannabis for Medical Purposes
- Authorized cannabis retailers in the provinces and territories
- Submit questions or concerns about cannabis
- Information for Municipalities - Medical Use of Cannabis
- Regulatory Initiative: Regulations Supporting the Proposed Cannabis Act - Forward Regulatory Plan 2018-2020
- Proposed Approach to the Regulation of Cannabis – Closed consultation
- Proposed Approach to the Regulation of Cannabis
- Information for Law Enforcement - Medical Use of Cannabis
- Access to Cannabis for Medical Purposes Regulations - Daily Amount Fact Sheet (Dosage)
- Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids
- Clinical Trial Applications (CTAs) - requirements
- Clinical Trial Application - Amendments (CTA-As)
- Clinical Trial Applications for Biologics and Radiopharmaceuticals
- Biosimilar biologic drugs in Canada: Fact Sheet
- Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
- Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document
- Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs)
- Guidance Document Harmonized Requirements for the Licensing of Vaccines and Guidelines for the Preparation of an Application
- Guidance document: Annual update of seasonal influenza vaccines
- Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences
- Guidance Document: Fecal Microbiota Therapy Used in the Treatment of Clostridium difficile Infection Not Responsive to Conventional Therapies
- Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors
- Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications
- Order to extend review period for clinical trial applications and amendments: Notice
- Guidance Document - Annex 13 to the Current Edition of the Good Manufacturing Practices Guidelines Drugs Used in Clinical Trials (GUI-0036)
- Guidance Document - Non-prescription Oral Adult Decongestant Cough and Cold Labelling Standard
- Guidelines for environmental control of drugs during storage and transportation (GUI-0069) - Summary
- Institution / Investigator Initiated Clinical Trials